HIGHLIGHTS
- who: Xun Gao and colleagues from the United States Capital Medical University, China have published the research: Characterization of METRNu03b2 as a novel biomarker of Coronavirus disease 2019 severity and prognosis, in the Journal: (JOURNAL)
- what: The authors propose METRNb as a novel broad anti-inflammatory protein. The authors propose that serum METRNb may be a surrogate indicator of COVID-19 based on the substantial differences in serum METRNb levels between non-Omicron-SARS-CoV-2 infected patients and healthy controls. The study showed that METRNb is a superior biomarker of COVID-19, because it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.